According to Sonoma Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.3571.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.3688 | -41.07% |
2022-12-31 | 0.6258 | -50.55% |
2021-12-31 | 1.27 | 3.25% |
2020-12-31 | 1.23 | 77.26% |
2019-12-31 | 0.6914 | 8.12% |
2018-12-31 | 0.6395 | -62.02% |
2017-12-31 | 1.68 | 81.31% |
2016-12-31 | 0.9286 | -57.54% |
2015-12-31 | 2.19 | 38.25% |
2014-12-31 | 1.58 | -78.67% |
2013-12-31 | 7.42 | 1.84% |
2012-12-31 | 7.28 | -95.8% |
2011-12-31 | 173 | 953.56% |
2010-12-31 | 16.4 | 100.83% |
2009-12-31 | 8.19 | -7.45% |
2008-12-31 | 8.85 | 56.46% |
2007-12-31 | 5.66 | |
2006-12-31 | N/A | |
2005-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6522 | 82.66% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.96 | 448.59% | ๐บ๐ธ USA |